Publicaciones en colaboración con investigadores/as de Universidad de Zaragoza (25)

2023

  1. Impact of physico-chemical properties on the toxicological potential of reduced graphene oxide in human bronchial epithelial cells

    Nanotoxicology, Vol. 17, Núm. 5, pp. 471-495

  2. Role of Chemical Reduction and Formulation of Graphene Oxide on Its Cytotoxicity towards Human Epithelial Bronchial Cells

    Nanomaterials, Vol. 13, Núm. 15

2022

  1. Genotoxicity of Graphene-Based Materials

    Nanomaterials, Vol. 12, Núm. 11

  2. In Vitro Genotoxicity Evaluation of an Antiseptic Formulation Containing Kaolin and Silver Nanoparticles

    Nanomaterials, Vol. 12, Núm. 6

2021

  1. Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors

    ChemMedChem, Vol. 16, Núm. 24, pp. 3730-3738

2019

  1. Co-encapsulation of superparamagnetic nanoparticles and doxorubicin in PLGA nanocarriers: Development, characterization and in vitro antitumor efficacy in glioma cells

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 145, pp. 65-75

2018

  1. Sex differences in ochratoxin a toxicity in F344 rats after 7 and 21 days of daily oral administration

    Food and Chemical Toxicology, Vol. 111, pp. 363-373

2017

  1. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261

  2. Visualization of hybrid gold-loaded polymeric nanoparticles in cells using scanning electron microscopy

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 315-320

2016

  1. A simple approach to obtain hybrid Au-loaded polymeric nanoparticles with a tunable metal load

    Nanoscale, Vol. 8, Núm. 12, pp. 6495-6506

  2. Bifunctional Chiral Dehydroalanines for Peptide Coupling and Stereoselective S-Michael Addition

    Organic Letters, Vol. 18, Núm. 12, pp. 2796-2799

  3. Design of α-S-Neoglycopeptides Derived from MUC1 with a Flexible and Solvent-Exposed Sugar Moiety

    Journal of Organic Chemistry, Vol. 81, Núm. 14, pp. 5929-5941

  4. Mucin Architecture behind the Immune Response: Design and Evaluation of an Antitumor Vaccine Derived from an Unnatural MUC1 Fragment

    Chemical Science, Vol. 7, Núm. 3, pp. 2294

  5. Stoichiometric and irreversible cysteine-selective protein modification using carbonylacrylic reagents

    Nature Communications, Vol. 7

  6. Tn Antigen Mimics Based on sp2-Iminosugars with Affinity for an anti-MUC1 Antibody

    Organic Letters, Vol. 18, Núm. 15, pp. 3890-3893

2015

  1. Deciphering the Non-Equivalence of Serine and Threonine O-glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody

    Angewandte Chemie International, Vol. 54, Núm. 34, pp. 9830

  2. Genotoxicity of Aflatoxin B1 and Ochratoxin A after simultaneous application of the in vivo micronucleus and comet assay

    Food and Chemical Toxicology, Vol. 76, pp. 116-124

2014

  1. Serine versus Threonine Glycosylation witha-O-GalNAc: Unexpected Selectivity in Their Molecular Recognition with Lectins

    Chemistry - A European Journal, Vol. 20, Núm. 39, pp. 12616-12627

2012

  1. Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles

    Journal of Controlled Release, Vol. 162, Núm. 3, pp. 553-560

  2. Gantrez AN nanoparticles for ocular delivery of memantine: In vitro release evaluation in albino rabbits

    Ophthalmic Research, Vol. 48, Núm. 3, pp. 109-117